Bayer bought Monsanto for $63 billion, a deal that quickly soured. Monsanto lost a major lawsuit after evidence showed it knew its product caused cancer but deliberately hid the information from the public, costing its new owner dearly.

Bayer's massive $63 billion purchase of Monsanto in 2018 quickly turned into a major problem. Only a few months after the deal closed, Monsanto lost its first big lawsuit over claims its product caused non-Hodgkin's lymphoma, a serious cancer. The case against the company was won because of internal documents that were made public during the trial. These documents revealed a shocking truth: Monsanto had information about the health dangers of its product but chose to hide it from consumers. The company knew about the potential harm but deliberately concealed the findings to protect its business. This decision to hide the truth was the key factor that led to the jury's verdict against them.

Original Author: Meryl Nass | Source: Brownstone Institute